Cyclin D1 rare variants in UK multiple adenoma and early-onset colorectal cancer patients

Journal of Human Genetics

Volumn 56, Issue 1, 2011, Pages 58-63

  Bonilla, Carolina ^a,b,f   Lefèvre, Jérémie H ^a,b,c   Winney, Bruce ^a   Johnstone, Elaine ^a   Tonks, Susan ^a   Colas, Chrystelle ^c,d   Day, Tammy ^a   Hutnik, Katarzyna ^a   Boumertit, Abdelhamid ^a   Midgley, Rachel ^a   Kerr, David ^a,e   Parc, Yann ^c   Bodmer, Walter F ^a,b  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b UNIVERSITY OF OXFORD   (United Kingdom)

^c HÔPITAL SAINT ANTOINE   (France)

^d PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^e SIDRA MEDICAL AND RESEARCH CENTER   (Qatar)

^f UNIVERSITY OF BRISTOL   (United Kingdom)

Author keywords

colorectal cancer; cyclin D1; multiple adenomas; rare variants; UK

Indexed keywords

CYCLIN D1;

ADULT; ARTICLE; CANCER PATIENT; CANCER RISK; COLORECTAL CANCER; CONTROLLED STUDY; EXON; FEMALE; GENE FREQUENCY; GENE SEQUENCE; GENETIC POLYMORPHISM; GENETIC SCREENING; GENETIC VARIABILITY; GENOTYPE; HUMAN; HUMAN TISSUE; INTESTINE POLYP; INTRON; MAJOR CLINICAL STUDY; MALE; PROMOTER REGION; UNITED KINGDOM; UNTRANSLATED REGION;

ADENOMA; ADULT; AGE OF ONSET; CASE-CONTROL STUDIES; COLORECTAL NEOPLASMS; CYCLIN D1; FEMALE; FRANCE; GENE FREQUENCY; GREAT BRITAIN; HUMANS; MALE; MIDDLE AGED; NEOPLASMS, MULTIPLE PRIMARY; POLYMORPHISM, SINGLE NUCLEOTIDE;

EID: 79251610650     PISSN: 14345161     EISSN: None     Source Type: Journal    
DOI: 10.1038/jhg.2010.144     Document Type: Article

References (49)

1. Howe, D. & Lynas, C. The cyclin D1 alternative transcripts [a] and [b] are expressed in normal and malignant lymphocytes and their relative levels are influenced by the polymorphism at codon 241. Haematologica. 86, 563-569 (2001).
2. Arber, N., Hibshoosh, H., Moss, S. F., Sutter, T., Zhang, Y., Begg, M. et al. Increased expression of cyclin D1 is an early event in multistage colorectal carcinogenesis. Gastroenterology. 110, 669-674 (1996).
3. McKay, J. A., Douglas, J. J., Ross, V. G., Curran, S., Murray, G. I. & Cassidy, J. Cyclin D1 protein expression and gene polymorphism in colorectal cancer.. Int. J. Cancer. 88, 77-81 (2000).
4. Ashton, K. A., Proietto, A., Otton, G., Symonds, I., McEvoy, M., Attia, J. et al. The influence of the Cyclin D1 870 G4A polymorphism as an endometrial cancer risk factor. BMC Cancer. 8, 272 (2008).
5. Wilding, J., Straub, J., Bee, J., Churchman, M., Bodmer, W., Dickson, C. et al. Cyclin D1 is not an essential target of beta-catenin signaling during intestinal tumorigenesis, but it may act as a modifier of disease severity in multiple intestinal neoplasia (Min) mice. Cancer Res. 62, 4562-4565 (2002).
6. Pabalan, N., Bapat, B., Sung, L., Jarjanazi, H., Francisco-Pabalan, O. & Ozcelik, H. Cyclin D1 Pro241Pro (CCND1-G870A) polymorphism is associated with increased cancer risk in human populations: a meta-analysis. Cancer Epidemiol. Biomarkers Prev. 17, 2773-2781 (2008).
7. Kong, S., Amos, C. I., Luthra, R., Lynch, P. M., Levin, B. & Frazier, M. L. Effects of cyclin D1 polymorphism on age of onset of hereditary nonpolyposis colorectal cancer. Cancer Res. 60, 249-252 (2000).
8. Talseth, B. A., Ashton, K. A., Meldrum, C., Suchy, J., Kurzawski, G., Lubinski, J. et al. Aurora-A and cyclin D1 polymorphisms and the age of onset of colorectal cancer in hereditary nonpolyposis colorectal cancer. Int. J. Cancer. 122, 1273-1277 (2008).
9. Chen, J., Etzel, C. J., Amos, C. I., Zhang, Q., Viscofsky, N., Lindor, N. M. et al. Genetic variants in the cell cycle control pathways contribute to early onset colorectal cancer in Lynch syndrome. Cancer Causes Control. 20, 1769-1777 (2009).
10. Kong, S., Wei, Q., Amos, C. I., Lynch, P. M., Levin, B., Zong, J. et al. Cyclin D1 polymorphism increased risk of colorectal cancer at young age. J. Natl. Cancer Inst. 93, 1106-1108 (2001). (Pubitemid 32717544)
11. Porter, T. R., Richards, F. M., Houlston, R. S., Evans, D. G. R., Jankowski, J. A., Macdonald, F. et al. Contribution of cyclin d1 (CCND1) and E-cadherin (CDH1) polymorphisms to familial and sporadic colorectal cancer. Oncogene. 21, 1928-1933 (2002).
12. Grünhage, F., Jungck, M., Lamberti, C., Berg, C., Becker, U., Schulte-Witte, H. et al. Association of familial colorectal cancer with variants in the E-cadherin (CDH1) and cyclin D1 (CCND1) genes. Int. J. Colorectal Dis. 23, 147-154 (2008).
13. Schernhammer, E. S., Tranah, G. J., Giovannucci, E., Chan, A. T., Ma, J., Colditz, G. A. et al. Cyclin D1 A870G polymorphism and the risk of colorectal cancer and adenoma. Br. J. Cancer. 94, 928-934 (2006).
14. Tan, X.- L., Nieters, A., Kropp, S., Hoffmeister, M., Brenner, H. & Chang-Claude, J. The association of cyclin D1 G870A and E-cadherin C-160A polymorphisms with the risk of colorectal cancer in a case control study and meta-analysis. Int. J. Cancer. 122, 2573-2580 (2008).
15. Bala, S. & Peltomaki, P. Cyclin D1 as a genetic modifier in hereditary nonpolyposis colorectal cancer. Cancer Res. 61, 6042-6045 (2001).
16. Kruger, S., Engel, C., Bier, A., Mangold, E., Pagenstecher, C., Von Knebel Doeberitz, M. et al. Absence of association between cyclin D1 (CCND1) G870A polymorphism and age of onset in hereditary nonpolyposis colorectal cancer. Cancer Lett. 236, 191-197 (2006).
17. Bodmer, W. Familial adenomatous polyposis (FAP) and its gene, APC. Cytogenet. Genome Res. 86, 99-104 (1999).
18. Fearnhead, N. S., Wilding, J. L., Winney, B., Tonks, S., Bartlett, S., Bicknell, D. C. et al. Multiple rare variants in different genes account for multifactorial inherited susceptibility to colorectal adenomas. Proc. Natl Acad. Sci. USA. 101, 15992-15997 (2004).
19. Bodmer, W. & Bonilla, C. Common and rare variants in multifactorial susceptibility to common diseases. Nat. Genet. 40, 695-701 (2008).
20. Frayling, I. M., Beck, N. E., Ilyas, M., Dove-Edwin, I., Goodman, P., Pack, K. et al. The APC variants I1307K and E1317Q are associated with colorectal tumors, but not always with a family history. Proc. Natl Acad. Sci. USA. 95, 10722-10727 (1998).
21. Lamlum, H., Al Tassan, N., Jaeger, E., Frayling, I., Sieber, O., Reza, F. B. et al. Germline APC variants in patients with multiple colorectal adenomas, with evidence for the particular importance of E1317Q. Hum. Mol. Genet. 9, 2215-2222 (2000).
22. Bodmer, W. F. & Bodmer, J. G. Cytofluorochromasia for HLA A, B, C and DR typing. In: NIAID Manual of Tissue Typing Techniques 1979-1980, Vol. 80. NIH Publication: Bethesda, MD, pp 545-546.
23. Ahn, S. J., Costa, J. & Rettig Emanuel, J. PicoGreen quantitation of DNA: effective evaluation of samples pre- or post-PCR. Nucleic Acids Res. 24, 2623-2625 (1996).
24. Liu, K. & Muse, S. V. PowerMarker: an integrated analysis environment for genetic marker analysis. Bioinformatics. 21, 2128-2129 (2005).
25. Barrett, J. C., Fry, B., Maller, J. & Daly, M. J. Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics. 21, 263-265 (2005).
26. Desmet, F.- O., Hamroun, D., Lalande, M., Collod-Béroud, G., Claustres, M. & Béroud, C. Human Splicing Finder: an online bioinformatics tool to predict splicing signals. Nucleic Acids Res. 37, e67 (2009).
27. Coassin, S., Brandstä tter, A. & Kronenberg, F. Lost in the space of bioinformatic tools: a constantly updated survival guide for genetic epidemiology. The GenEpi Toolbox. Atherosclerosis. 209, 321-335 (2010).
28. Comstock, C. E. S., Augello, M. A., Benito, R. P., Karch, J., Tran, T. H., Utama, F. E. et al. Cyclin D1 splice variants: polymorphism, risk, and isoform-specific regulation in prostate cancer. Clin. Cancer Res. 15, 5338-5349 (2009).
29. Eto, I. Molecular cloning and sequence analysis of the promoter region of mouse cyclin D1 gene: implication in phorbol ester-induced tumour promotion. Cell Prolif. 33, 167-187 (2000).
30. Nagata, D., Suzuki, E., Nishimatsu, H., Satonaka, H., Goto, A., Omata, M. et al. Transcriptional activation of the cyclin D1 gene is mediated by multiple cis-elements, including SP1 sites and a cAMP-responsive element in vascular endothelial cells. J. Biol. Chem. 276, 662-669 (2001).
31. Bartusel, T., Schubert, S. & Klempnauer, K.- H. Regulation of the cyclin D1 and cyclin A1 promoters by B-Myb is mediated by Sp1 binding sites. Gene. 351, 171-180 (2005).
32. Wiestner, A., Tehrani, M., Chiorazzi, M., Wright, G., Gibellini, F., Nakayama, K. et al. Point mutations and genomic deletions in CCND1 create stable truncated cyclin D1 mRNAs that are associated with increased proliferation rate and shorter survival. Blood. 109, 4599-4606 (2007).
33. Sathyan, K. M., Nalinakumari, K. R., Abraham, T. & Kannan , S. CCND1 polymorphisms (A870G and C1722G) modulate its protein expression and survival in oral carcinoma. Oral Oncol. 44, 689-697 (2008).
34. Hosokawa, Y., Suzuki, R., Joh, T., Maeda, Y., Nakamura, S., Kodera, Y. et al. A small deletion in the 3¢-untranslated region of the cyclin D1/PRAD1/bcl-1 oncogene in a patient with chronic lymphocytic leukemia. Int. J. Cancer. 76, 791-796 (1998).
35. Deshpande, A., Pastore, A., Deshpande, A. J., Zimmermann, Y., Hutter, G., Weinkauf, M. et al. 3¢UTR mediated regulation of the cyclin D1 proto-oncogene. Cell Cycle. 8, 3584-3592 (2009).
36. Felix, R., Bodmer, W., Fearnhead, N. S., van der Merwe, L., Goldberg, P. & Ramesar, R. S. GSTM1 and GSTT1 polymorphisms as modifiers of age at diagnosis of hereditary nonpolyposis colorectal cancer (HNPCC) in a homogeneous cohort of individuals carrying a single predisposing mutation. Mut. Res. 602, 175-181 (2006).
37. Cohen, J. C., Kiss, R. S., Pertsemlidis, A., Marcel, Y. L., McPherson, R. & Hobbs, H. H. Multiple rare alleles contribute to low plasma levels of HDL cholesterol. Science. 305, 869-872 (2004).
38. Pritchard, J. K. & Cox, N. J. The allelic architecture of human disease genes: common disease-common variant.or not? Hum. Mol. Genet. 11, 2417-2423 (2002).
39. Schork, N. J., Murray, S. S., Frazer, K. A. & Topol, E. J. Common vs. rare allele hypotheses for complex diseases. Curr. Opin. Genet. Dev. 19, 212-219 (2009).
40. Goldstein, D. B. Common genetic variation and human traits. New Eng. J. Med. 360, 1696-1698 (2009).
41. Eyre-Walker, A. Evolution in health and medicine Sackler colloquium: genetic architecture of a complex trait and its implications for fitness and genome-wide association studies. Proc. Natl Acad. Sci. USA. 107, 1752-1756 (2010).
42. Nejentsev, S.,Walker, N., Riches, D., Egholm, M. & Todd, J. A. Rare variants of IFIH1, a gene implicated in antiviral responses, protect against type 1 diabetes. Science. 324, 387-389 (2009).
43. Kaufmann, A., Vogt, S., Uhlhaas, S., Stienen, D., Kurth, I., Hameister, H. et al. Analysis of rare APC variants at the mRNA level: six pathogenic mutations and literature review. J. Mol. Diagn. 11, 131-139 (2009).
44. Azzopardi, D., Dallosso, A. R., Eliason, K., Hendrickson, B. C., Jones, N., Rawstorne, E. et al. Multiple rare nonsynonymous variants in the adenomatous polyposis coli gene predispose to colorectal adenomas. Cancer Res. 68, 358-363 (2008).
45. Mefford, H. C., Cooper, G. M., Zerr, T., Smith, J. D., Baker, C., Shafer, N. et al. A method for rapid, targeted CNV genotyping identifies rare variants associated with neurocognitive disease. Genome Res. 19, 1579-1585 (2009).
46. Burnett, J. R. & Hooper, A. J. Common and rare gene variants affecting plasma LDL cholesterol. Clin. Biochem. Rev. 29, 11-26 (2008).
47. Cohen, J. C., Pertsemlidis, A., Fahmi, S., Esmail, S., Vega, G. L., Grundy, S. M. et al. Multiple rare variants in NPC1L1 associated with reduced sterol absorption and plasma low-density lipoprotein levels. Proc. Natl Acad. Sci. USA. 103, 1810-1815 (2006).
48. Walsh, T., McClellan, J. M., McCarthy, S. E., Addington, A. M., Pierce, S. B., Cooper, G. M. et al. Rare structural variants disrupt multiple genes in neurodevelopmental pathways in schizophrenia. Science. 320, 539-543 (2008).
49. Bearden, C. E., Glahn, D. C., Lee, A. D., Chiang, M.- C., Van Erp, T. G. M., Cannon, T. D. et al. Neural phenotypes of common and rare genetic variants. Biol. Psychol. 79, 43-57 (2008).